Table 6.
Effective assessment of INTP in transoral endoscopic thyroidectomy.
| INTP group (n = 200) | Control group (n = 225) | p-Value | |
|---|---|---|---|
| EMG changes (%) | 14 (7.0%) | 25 (11.1%) | 0.143 |
| Hoarseness (%) | 3 (1.5%) | 13 (5.8%) | 0.021 |
| Postoperative PTH (pg/ml) | 33.1 ± 17.1 | 30.0 ± 16.3 | 0.053 |
| Postoperative calcium | 2.14 ± 0.13 | 2.09 ± 0.13 | < 0.01 |
| Numbness in limbs (%) | 27 (13.5%) | 34 (15.1%) | 0.636 |
| Total number of CLN | 9.42 ± 5.79 | 9.94 ± 6.32 | 0.377 |
| Number of metastatic CLN | 1.74 ± 2.41 | 2.13 ± 2.63 | 0.110 |
| WBC (×109/L) | 8.9 ± 2.5 | 9.8 ± 5.3 | 0.047 |
| Postoperative CRP (mg/L) | 6.7 ± 5.9 | 8.7 ± 6.9 | < 0.01 |
| Operative time (min) | 91.9 ± 33.3 | 92.4 ± 33.6 | 0.883 |
| Hospital stay (days) | 3.4 ± 1.2 | 3.4 ± 1.2 | 0.874 |
| Cosmetic satisfaction | 7.88 ± 0.74 | 7.76 ± 0.76 | 0.100 |
CLN, central lymph nodes; INTP, intraoperative neural tunnel protecting; EMG, electromyography; PTH, parathyroid hormone; WBC, white blood cell; CRP, C-reactive protein.